Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
CPRX [NASD]
Catalyst Pharmaceutical Partners Inc.
Index- P/E- EPS (ttm)-0.28 Insider Own9.30% Shs Outstand67.18M Perf Week4.03%
Market Cap173.32M Forward P/E- EPS next Y-0.22 Insider Trans12.52% Shs Float60.54M Perf Month-10.73%
Income-14.30M PEG- EPS next Q-0.05 Inst Own33.70% Short Float9.51% Perf Quarter10.26%
Sales- P/S- EPS this Y-92.90% Inst Trans0.04% Short Ratio4.26 Perf Half Y29.00%
Book/sh0.62 P/B4.16 EPS next Y0.00% ROA-46.80% Target Price7.00 Perf Year33.68%
Cash/sh0.67 P/C3.85 EPS next 5Y- ROE-55.90% 52W Range1.29 - 3.49 Perf YTD32.31%
Dividend- P/FCF- EPS past 5Y19.70% ROI- 52W High-26.07% Beta0.96
Dividend %- Quick Ratio19.10 Sales past 5Y- Gross Margin- 52W Low100.00% ATR0.21
Employees7 Current Ratio19.10 Sales Q/Q- Oper. Margin- RSI (14)46.48 Volatility7.20% 8.62%
OptionableYes Debt/Eq0.00 EPS Q/Q37.50% Profit Margin- Rel Volume0.38 Prev Close2.68
ShortableYes LT Debt/Eq0.00 EarningsNov 10 Payout- Avg Volume1.35M Price2.58
Recom2.00 SMA20-2.33% SMA50-7.83% SMA20011.60% Volume518,181 Change-3.73%
30-Sep-14Reiterated ROTH Capital Buy $5 → $6
16-Sep-14Reiterated ROTH Capital Buy $3.50 → $5
15-Sep-14Reiterated H.C. Wainwright Buy $5 → $13
21-Oct-13Reiterated Aegis Capital Buy $4 → $5.50
24-Sep-13Initiated Maxim Group Buy $4
06-Sep-13Reiterated Aegis Capital Buy $3.50 → $4
18-Apr-13Initiated Aegis Capital Buy $2.50
27-Aug-12Upgrade Rodman & Renshaw Mkt Perform → Mkt Outperform $3.70
01-Oct-09Upgrade Merriman Sell → Neutral
29-May-09Downgrade Merriman Curhan Ford Buy → Sell
29-May-09Downgrade Hapoalim Neutral → Underperform
15-Dec-08Initiated Merriman Curhan Ford Buy
28-Nov-07Initiated Rodman & Renshaw Mkt Outperform $9
31-Jan-07Initiated Stifel Nicolaus Buy $9
05-Jan-07Initiated First Albany Buy $10
08-Oct-14 01:11PM  Midday Gainers From October 8 - GT Advanced Technologies Inc, Unilife Corp And More Benzinga +6.43%
08:03AM  Catalyst Pharmaceuticals to Present Top-Line Safety and Efficacy Results From Phase 3 Firdapse Trial at 139th Annual Meeting of the American Neurological Association GlobeNewswire
03-Oct-14 09:41AM  Biotech Stock Mailbag: Seattle Genetics, Achillion, Catalyst Pharma at TheStreet
02-Oct-14 08:03AM  Catalyst Pharmaceuticals to Present at 13th Annual BIO Investor Forum GlobeNewswire
30-Sep-14 04:18PM  What Else Is Under the Hood for Catalyst Pharma? at 24/7 Wall St. +11.04%
03:09PM  Why Catalyst Pharmaceutical Partners (CPRX) Stock Is Spiking Today at TheStreet
07:20AM  Catalyst Pharma Closer to Unconscionable Price Hike for Rare-Disease Drug at TheStreet
29-Sep-14 05:48PM  Ford slips on Europe woes, Cintas, Synnex up on earnings at MarketWatch
04:10PM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
04:05PM  Catalyst Pharma's lead drug succeeds in late-stage study Reuters
04:03PM  Catalyst Pharmaceuticals Announces Positive Top-Line Phase 3 Data From Pivotal Firdapse Clinical Trial in Patients With Lambert-Eaton Myasthenic Syndrome (LEMS) GlobeNewswire
05-Sep-14 06:38AM  Catalyst Pharmaceutical (CPRX) Jumps: Stock Up 9% Zacks
04-Sep-14 08:45AM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online +8.95%
08:03AM  Catalyst Pharmaceuticals Appoints David D. Muth as Executive Vice President, Corporate Development GlobeNewswire
03-Sep-14 08:03AM  Catalyst Pharmaceutical Partners to Present at Rodman & Renshaw's 16th Annual Global Investment Conference GlobeNewswire
02-Sep-14 04:21PM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08:03AM  Catalyst Pharmaceutical Partners Initiates Phase 1(b) Safety and Tolerance Study for CPP-115 GlobeNewswire
28-Aug-14 06:48AM  Why Catalyst Pharmaceutical (CPRX) Could Be Positioned for a Surge? Zacks
26-Aug-14 09:50AM  Your September Biotech Back-to-School Calendar at TheStreet +15.89%
07:50AM  Catalyst Pharmaceutical Partners (CPRX) Worth Watching: Stock Up 10.3% Zacks
22-Aug-14 01:04PM  CATALYST PHARMACEUTICAL PARTNERS, INC. Financials EDGAR Online Financials
14-Aug-14 08:15AM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08:03AM  Catalyst Pharmaceutical Partners Announces Second Quarter 2014 Financial Results GlobeNewswire
13-Aug-14 04:38PM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
11-Aug-14 08:15AM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08:03AM  Catalyst Pharmaceutical Partners Provides Updates on Progress of Phase 3 Firdapse Study in Patients With Lambert-Eaton Myasthenic Syndrome (LEMS) GlobeNewswire
01-Aug-14 08:06AM  Biotech Stock Mailbag: Arrowhead, Catalyst Pharma at TheStreet
19-Jun-14 08:03AM  Catalyst Pharmaceutical Partners to Present at the JMP Securities 2014 Healthcare Conference GlobeNewswire
18-Jun-14 01:03PM  Catalyst Pharmaceutical Partners Set to Join Russell Microcap(R) Index GlobeNewswire
29-May-14 08:03AM  Catalyst Pharmaceutical Partners to Present at the Jefferies 2014 Global Healthcare Conference GlobeNewswire +5.83%
19-May-14 04:20PM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of M EDGAR Online
16-May-14 08:28AM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08:06AM  Catalyst Pharmaceutical reports Q1 EPS (4c), consensus (6c) at theflyonthewall.com
08:03AM  Catalyst Pharmaceutical Partners Announces First Quarter 2014 Financial Results and Provides Corporate Update GlobeNewswire
15-May-14 07:00PM  The Shuman Law Firm Investigates Catalyst Pharmaceutical Partners, Inc. Business Wire
04:28PM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
23-Apr-14 08:40AM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08:03AM  Catalyst Announces Initiation of an Expanded Access Program to Provide Firdapse at No Cost to U.S. Patients with Lambert-Eaton Myasthenic Syndrome Business Wire
17-Apr-14 04:56PM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Stat EDGAR Online
09-Apr-14 02:58PM  A Small-Cap Biotech Stock on the Verge of a Breakout at TheStreet
08-Apr-14 10:58AM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online +7.77%
10:30AM  Catalyst Pharmaceutical Partners, Inc. Announces Closing of Previously Announced Public Offering GlobeNewswire
04-Apr-14 02:01AM  Catalyst Pharmaceutical Partners Inc. (CPRX) Jumps: Stock Up 8.6% Zacks -5.83%
03-Apr-14 04:32PM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Stat EDGAR Online +8.60%
09:00AM  Catalyst Pharmaceutical Partners, Inc. Prices Public Offering of Common Stock GlobeNewswire
02-Apr-14 04:05PM  Catalyst Pharmaceutical files to sell common stock, no amount given at theflyonthewall.com
04:04PM  Catalyst Pharmaceutical Partners, Inc. Announces Commencement of Public Offering of Common Stock GlobeNewswire
01-Apr-14 12:59PM  [$$] 7 Stock Picks From an Insider Trading Guru at Barrons.com
08:19AM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08:03AM  Catalyst Announces Completion of Enrollment in Pivotal Phase 3 Trial of Firdapse(TM) in Patients With Lambert-Eaton Myasthenic Syndrome GlobeNewswire
28-Mar-14 08:36AM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08:06AM  Catalyst Pharmaceutical names Barrett McGrath as Chief Commercial Officer theflyonthewall.com
08:03AM  Catalyst Pharmaceutical Partners Expands Executive Leadership Team to Support the Commercialization of Firdapse(TM) GlobeNewswire
26-Mar-14 05:30PM  Good News for Catalyst Pharma Zacks
25-Mar-14 04:51PM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08:03AM  Catalyst Pharmaceutical Partners Announces Recommendation of Data Monitoring Committee to Continue Pivotal Phase 3 Clinical Trial for Firdapse(TM) GlobeNewswire
21-Mar-14 06:11AM  Catalyst Pharmaceutical Partners (CPRX) in Focus: Stock Moves 6.2% Higher Zacks
20-Mar-14 05:17PM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online +6.22%
08:20AM  Narrower-than-Expected Loss at Catalyst Pharma Zacks
19-Mar-14 08:03AM  Catalyst Pharmaceutical Partners Announces Fourth Quarter and Year-End 2013 Financial Results and Provides Corporate Update GlobeNewswire
06:02AM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 10-K, Annual Report EDGAR Online
06-Mar-14 08:03AM  Catalyst Pharmaceutical Partners to Present at the 26th Annual ROTH Conference GlobeNewswire
04-Mar-14 05:03PM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD D EDGAR Online
28-Feb-14 08:03AM  Catalyst Pharmaceutical Partners Observes Rare Disease Day Today GlobeNewswire
20-Feb-14 04:34PM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Stat EDGAR Online +11.68%
06-Feb-14 08:03AM  Catalyst Pharmaceutical Partners to Present at 16th Annual BIO CEO & Investor Conference GlobeNewswire
08-Jan-14 08:24AM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online +5.94%
08:03AM  Catalyst Pharmaceutical Partners Reports Positive Cardiac Safety Results of Its Phase 3 Product, Firdapse Tablets GlobeNewswire
07-Jan-14 08:14AM  Catalyst Pharmaceutical announces dismissal of stockholder class action lawsuit at theflyonthewall.com
08:03AM  Catalyst Pharmaceutical Partners Reports Dismissal of Stockholder Class Action Lawsuit GlobeNewswire
06-Jan-14 08:15AM  Catalyst reports successful completion of Type B therapy meeting with FDA at theflyonthewall.com
08:03AM  Catalyst Pharmaceutical Partners Reports Successful Completion of Type B Breakthrough Therapy Meeting With FDA on Firdapse Tablets Development Program GlobeNewswire
20-Dec-13 09:30PM  Glancy Binkow & Goldberg LLP Announces a December 24, 2013 Lead Plaintiff Deadline in the Class Action Lawsuit Against Catalyst Pharmaceutical Partners, Inc. -- CPRX GlobeNewswire
17-Dec-13 06:50PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Catalyst Pharmaceutical Partners, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 24, 2013 Business Wire
03:14AM  EQUITY ALERT: Rosen Law Firm Reminds Catalyst Pharmaceutical Partners Investors of Important December 24, 2013 Deadline in Class Action -- CPRX GlobeNewswire
12-Dec-13 12:27PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Catalyst Pharmaceutical Partners, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 24, 2013 -- CPRX Marketwired
10-Dec-13 09:32PM  Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline in the Class Action Lawsuit Against Catalyst Pharmaceutical Partners, Inc. Business Wire
09-Dec-13 04:21PM  DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders of Catalyst Pharmaceutical Partners, Inc. of Upcoming Deadline Business Wire -6.22%
06-Dec-13 09:32PM  Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Catalyst Pharmaceutical Partners, Inc. Business Wire
Catalyst Pharmaceutical Partners, Inc. operates as development-stage specialty pharmaceutical company. The company focuses on the development and commercialization of novel prescription drugs targeting rare (orphan) neuromuscular and neurological diseases and disorders. Its principal product candidate is Firdapse, a proprietary form of amifampridine phosphate, which is in Phase III clinical trial for the treatment of Lambert-Eaton Myasthenic Syndrome. The company also develops CPP-115, a vigabatrin analog to treat infantile spasms and epilepsy, as well as other neurological conditions associated with reduced GABAergic signaling, such as post-traumatic stress disorder and Tourette syndrome. Catalyst Pharmaceutical Partners, Inc. has strategic collaboration agreement with BioMarin. The company was founded in 2002 and is based in Coral Gables, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Winship M DouglasVP, Regulatory OperationsOct 17Option Exercise0.90125,000112,500142,294Oct 20 04:34 PM
Tierney David SDirectorOct 16Option Exercise0.9030,00027,000243,401Oct 20 04:33 PM
MUTH DAVID DExec. V.P., Corp. DevelopmentOct 03Buy2.6510,00026,50020,000Oct 07 04:26 PM
MCENANY PATRICK JPresident and CEOOct 02Option Exercise0.90150,000135,0003,920,918Oct 03 01:03 PM
GRANDE ALICIAVP, Treasurer and CFOOct 02Option Exercise0.9090,00081,000156,346Oct 03 12:56 PM
O'Keeffe Charles BDirectorOct 02Option Exercise0.90105,00094,500297,126Oct 03 02:25 PM
Miller SteveChief Operating OfficerOct 02Option Exercise0.90175,000157,500389,754Oct 03 02:26 PM
HUCKEL HUBERT E MDDirectorOct 02Option Exercise0.9030,00027,0001,334,134Oct 06 04:29 PM
COELHO PHILIP HDirectorOct 02Option Exercise0.9020,03618,032141,636Oct 06 04:28 PM
Miller SteveChief Operating OfficerJun 04Buy2.17100,000216,990214,754Jun 04 06:39 PM
MCENANY PATRICK JPresident and CEOMay 21Buy1.8925,00047,2253,656,247May 21 04:15 PM
O'Keeffe Charles BDirectorMay 19Buy1.8310,00018,291192,126May 21 04:13 PM
O'Keeffe Charles BDirectorApr 16Buy2.025,00010,100182,126Apr 17 07:56 PM
MCENANY PATRICK JPresident and CEOFeb 07Buy1.8225,00045,5003,631,247Feb 07 02:04 PM
O'Keeffe Charles BDirectorFeb 05Buy1.8110,00018,099177,126Feb 06 04:08 PM